Exmocare is set to unveil the BT2 on March 14, a new and improved Bluetooth human-diagnostic/human-tracking wristwatch with onboard display, better accuracy and smaller form factor. The BT2 will enable potential distributors to evaluate the company's revolutionary wristwatches. All reports indicate that the global market growth for new medical devices continues to grow sharply.

- The medical device market in the United States should be approximately $86 billion by the end of 2006 (close to $220 billion worldwide), with a 10% annual growth rate expected for the coming year (Source: AdvaMed 2006)

- The medical device industry in Canada has approximately $5 billion in sales (Source: www.medec.org, 2007).

- According to the latest U.S. Economic Census, the electromedical and electrotherapeutic apparatus manufacturing industry was worth $13.61 billion in 2002, up approximately 44.6% in just five years (Source: U.S. Census Bureau).

Exmocare developed a revolutionary, limited edition wearable medical monitoring wristwatch, called the BT1, that tracks several key vital signs 24/7 and then stores the information and transmits data to a caregiver or family member. The BT1 has been used since 2006 for research missions by NASA, evaluation by research universities and clinics, and has been recognized for its unique capabilities by Frost and Sullivan. The advanced BT2 builds on the critical success of the BT1 and will be produced in larger quantities for evaluation by chronic and elder care service plan providers spanning 190 countries.

Unlike any other biosensor device on the planet, the BT2 measures and transmits all basic vital signs needed via Bluetooth to alert care providers 24/7. With its sleeker appearance, smaller form factor and onboard display, the BT2 will enable Exmocare to demonstrate its online diagnosis and electronic medical record storage services globally. The BT2 will be debuted at an industry award ceremony honoring the BT1 on March 14 in San Francisco, where its final specifications will be revealed to the general public. Amazing features of Exmocare's BT2 monitoring device:

- 99 Percent accurate vital signs, even when the wearer is moving

- Heart rate and heart rate variability in the Exmocare watch using infrared signals to determine blood volume pulse without chest straps, electrodes or two-handed contact

- Simultaneously measures skin temperature, skin moisture and relative movement Able to detect human emotional and behavioral states, including side effects to drugs

- Connects to online diagnosis and electronic medical records software via Bluetooth wireless Exmocare already has a waiting list of BT2 evaluation kit customers in Canada, the United States, the United Kingdom, France, Germany, South Africa, Japan and Korea, and is actively in talks with potential new distributors in those markets.

Stay connected!

RSS    Save to Del.icio.us  Digg This